Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Sea Mild Biotechnology Co's enterprise value is NT$208.6 Mil.
Sea Mild Biotechnology Co's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was NT$32.0 Mil. Therefore, Sea Mild Biotechnology Co's EV-to-EBITDA for today is 6.51.
The historical rank and industry rank for Sea Mild Biotechnology Co's EV-to-EBITDA or its related term are showing as below:
ROCO:7516'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -221.75 Med: -3.42 Max: 25.47
Current: 6.51
During the past 12 years, the highest EV-to-EBITDA of Sea Mild Biotechnology Co was 25.47. The lowest was -221.75. And the median was -3.42.
ROCO:7516's EV-to-EBITDA is ranked better than 69.33% of 1650
companies
in the Consumer Packaged Goods industry
Industry Median: 9.155
vs ROCO:7516: 6.51
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Sea Mild Biotechnology Co (ROCO:7516) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Sea Mild Biotechnology Co's PE Ratio (TTM) for today is calculated as:
Sea Mild Biotechnology Co's share price for today is NT$8.40.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sea Mild Biotechnology Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was NT$0.350.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:7516 vs PG, CL, KVUE: EV-to-EBITDA Comparison
For the Household & Personal Products subindustry, Sea Mild Biotechnology Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sea Mild Biotechnology Co EV-to-EBITDA vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Sea Mild Biotechnology Co's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Sea Mild Biotechnology Co's EV-to-EBITDA falls into.
Sea Mild Biotechnology Co's current Enterprise Value is NT$208.6 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sea Mild Biotechnology Co's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was NT$32.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sea Mild Biotechnology Co (ROCO:7516) has a EV-to-EBITDA of 6.51 as of Aug. 23, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Sea Mild Biotechnology Co. According to the industry distribution chart, Sea Mild Biotechnology Co ranks #506 out of 1650 companies in the Consumer Packaged Goods industry, placing it in the top 30.7%.
Is Sea Mild Biotechnology Co's EV-to-EBITDA too high?
Sea Mild Biotechnology Co's current EV-to-EBITDA is 6.51. The Consumer Packaged Goods industry median EV-to-EBITDA is 9.16. Sea Mild Biotechnology Co's value of 6.51 is 28.9% below this industry median. Based on the distribution chart, Sea Mild Biotechnology Co ranks #506 out of 1650 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Sea Mild Biotechnology Co has a GF Score™ of 69/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Sea Mild Biotechnology Co's EV-to-EBITDA compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Sea Mild Biotechnology Co ranks #506 out of 1650 companies for EV-to-EBITDA. This puts Sea Mild Biotechnology Co in the upper half of its industry. The industry median EV-to-EBITDA is 9.16. Sea Mild Biotechnology Co's value of 6.51 is 28.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Consumer Packaged Goods company?
The median EV-to-EBITDA among Consumer Packaged Goods companies is 9.16, based on 1,650 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sea Mild Biotechnology Co's current EV-to-EBITDA of 6.51 is 28.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Sea Mild Biotechnology Co. For the Consumer Packaged Goods industry, the median EV-to-EBITDA is 9.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sea Mild Biotechnology Co's current EV-to-EBITDA is 6.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sea Mild Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, Sea Mild Biotechnology Co (ROCO:7516) is currently considered Possible Value Trap. The stock's GF Value™ is NT$13.67, compared to a current price of NT$8.40 — trading 38.6% below its estimated fair value. The current EV-to-EBITDA is 6.51 and 28.9% below the Consumer Packaged Goods industry median of 9.16. Sea Mild Biotechnology Co's overall GF Score™ is 69/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Sea Mild Biotechnology Co (ROCO:7516), the current EV-to-EBITDA is 6.51 as of Aug. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sea Mild Biotechnology Co (ROCO:7516) Overvalued in 2026?
Based on GuruFocus' analysis, Sea Mild Biotechnology Co stock appears to be undervalued.
The current stock price of NT$8.40 is trading 38.6% below its estimated GF Value™ of NT$13.67.
GuruFocus considers Sea Mild Biotechnology Co to be Possible Value Trap.
Key valuation signals for ROCO:7516:
EV-to-EBITDA: 6.51
GF Value™: NT$13.67 vs. price of NT$8.40 (38.6% below fair value)
Industry Position: 28.9% below the Consumer Packaged Goods median (#506 of 1650)
No single metric tells the full story. See the ROCO:7516 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sea Mild Biotechnology Co Ltd is a manufacturer and distributor of household products. The company's products portfolio includes washing powder, laundry detergent, home cleaning products, personal cleaning and care products, and shampoo.
69GF Score
Get the complete analysis for ROCO:7516
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:7516 has been successfully added to your 
